Clinical Trial Recruitment in Respiratory Diseases - Most Clinical Trial Activity Focused on Asthma and COPD - GBI Research Reports

Clinical Trial Recruitment in Respiratory Diseases - Most Clinical Trial Activity Focused on Asthma and COPD

Clinical Trial Recruitment in Respiratory Diseases - Most Clinical Trial Activity Focused on Asthma and COPD - GBI Research Reports
Clinical Trial Recruitment in Respiratory Diseases - Most Clinical Trial Activity Focused on Asthma and COPD
Published Nov 22, 2011
76 pages — Published Nov 22, 2011
Price US$ 3,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GBI Researchs report, Clinical Trial Recruitment in Respiratory Diseases - Most Clinical Trial Activity Focused on Asthma and COPD, provides an in-depth analysis of patient recruitment scenario for major indications under respiratory diseases. The report analyzes the number of clinical trials conducted for major indications. The report provides information about the total number of clinical trials conducted by phase, geography, major sponsors and the number of clinical trials conducted per year. Analysis of the total number of patients recruited for major indications is also carried out. The report analyzes the total number of patients recruited by phase of clinical trial, geography and major sponsors. Analysis of the average number of patients recruited per trial per year for various indications is also completed.

Clinical trials are conducted to find novel therapies for respiratory diseases. The cost and time for conducting clinical trials for respiratory diseases is higher than other diseases. This is due to costly and time consuming testing methods. Patients are required to be tested for a longer duration leading to an increase in the total time required for drug effectiveness than seen in other diseases. Changing environmental conditions along with increases in tobacco smoking, air pollution and urbanization has lead to an increase in the prevalence of respiratory diseases. Asthma, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis (CF) and Pulmonary Arterial Hypertension (PAH) are few of the major respiratory diseases for which an increased number of clinical trials are conducted in order to determine the most effective treatment.

In accordance to World Health Organization (WHO), the most common chronic disease among children is asthma. Asthma affects nearly 235 million people in the world. COPD was the cause of 5% of the total deaths in 2005. Tobacco smoking is the leading cause of COPD and in 2030. COPD will be the third leading cause of death. In light if this it becomes more important to find remedies for chronic respiratory diseases. CF is one of the most prevalent life-shortening diseases. It is a genetic disease which affects multiple organs.

It is important to recruit the right type and number of patients to check the efficacy and efficiency of drugs. Efficient patient recruitment leads to a decrease in the time and cost associated with patient recruitment. At present, the rate of new drug approvals is declining with every passing year. Pharmaceutical companies are under intense pressure to reduce the time required for drug development. There are many barriers to participation for the patients as well as the investigators who enroll patients into the trials. Advances in the diagnosis and treatment of respiratory diseases are leading to a greater interest of pharmaceutical companies in sponsoring research into respiratory diseases.

Scope

- Insight on Clinical Trials conducted for major indications of respiratory diseases such as asthma, COPD, CF, PAH or Pulmonary Hypertension (PH) for the period 20002010.
- The status of patient recruitment by geographical region, sponsor company, year and stage of development.
- Analysis on the average number of patients recruited per trial for major indications per year.
- Analysis on the average number of patients recruited per trial for major indications by stage of development.
- The prevalence population in India, China and Brazil for all major indications from 2010-2017.

Reasons to buy

- Identify and understand the status of clinical trials conducted for major respiratory indications from 2000-2010.
- Build understanding of patient recruitment status by geography, sponsor company, year and stage of development.
- Identify the p

  
Source:
Document ID
GBIHC158MR
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents36
  List of Tables52
  List of Figures72
Clinical Trial Recruitment in Respiratlory Diseases - Introduction92
  Introduction91
  GBI Research Report Guidance92
Clinical Trial Recruitment in Respiratory Diseases - Overview118
  Clinical Trials Share by Therapeutic Area, 2005-2010117
  Clinical Trials by Major Pharmaceutical Companies, 2005-2010181
Clinical Trials and Patient Recruitment for Asthma1914
  Introduction191
  Number of Clinical Trials for Asthma201
    Number of Clinical Trials by Phase201
    Number of Clinical Trials for Asthma by Major Sponsors211
    Number of Clinical Trials for Asthma by Geography221
    Number of Clinical Trials for Asthma by Year231
  Prevalence Population for Asthma (2010-2017)241
    India241
    China251
    Brazil261
  Patient Recruitment for Asthma271
    Number of Patients Recruited by Phase of Clinical Trials271
    Number of Patients Recruited by Major Sponsors281
    Number of Patients Recruited by Geography291
    Number of Patients Recruited per Year301
  Average Number of Patients Recruited Per Trial311
    Average Number of Patients Recruited per Trial by Stage of Development311
    Average Number of Patients Recruited per Trial per Year321
Clinical Trials and Patient Recruitment for COPD3314
  Introduction331
  Number of Clinical Trials for COPD341
    Number of Clinical Trials by Phase341
    Number of Clinical Trials by Sponsor351
    Number of Clinical Trials by Geography361
    Number of Clinical Trials by Year371
  Prevalence Population for COPD (2010-2017)381
    India381
    China391
    Brazil401
  Patient Recruitment for COPD411
    Number of Patients Recruited By Phase of Clinical Trial411
    Number of Patients Recruited By Sponsor421
    Number of Patients Recruited By Geography431
    Number of Patients Recruited per Year441
  Average Number of Patients Recruited Per Trial451
    Average Number of Patients Recruited per Trial by Stage of Development451
    Average Number of Patients Recruited per Trial per Year461
Clinical Trials and Patient Recruitment for Cystic Fibrosis (CF)4711
  Introduction471
  Number of Clinical Trials for CF481
    Number of Clinical Trials by Phase481
    Number of Clinical Trials by Major Sponsor491
    Number of Clinical Trials by Geography501
    Number of Clinical Trials by Year511
  Patient Recruitment for CF521
    Number of Patients Recruited By Phase of Clinical Trial521
    Number of Patients Recruited by Major Sponsors531
    Number of Patients Recruited by Geography541
    Number of Patients Recruited per Year551
  Average Number of Patients Recruited Per Trial by Stage of Development561
    Average Number of Patients Recruited per Trial by Stage of Development561
    Average Number of Patients Recruited per Trial per Year571
Clinical Trials and Patient Recruitment for Pulmonary Hypertension (PH)/ Pulmonary Arterial Hypertension (PAH)5814
  Introduction581
  Number of Clinical Trials for PH591
    Number of Clinical Trials by Phase591
    Number of Clinical Trials by Major Sponsors601
    Number of Clinical Trials by Geography611
    Number of Clinical Trials by Year621
  Prevalence Population for Pulmonary Hypertension (2010-2017)631
    India631
    China641
    Brazil651
  Patient Recruitment for PH661
    Number of Patients Recruited By Phase of Clinical Trial661
    Number of Patients Recruited by Major Sponsors671
    Number of Patients Recruited By Geography681
    Number of Patients Recruited Per Year691
  Average Number of Patients Recruited Per Trial by Stage of Development701
    Average Number of Patients Recruited per Trial by Stage of Development701
    Average Number of Patients Recruited per Trial per Year711
Appendix725
  Market Definitions721
  Abbreviations721
  Research Methodology733
    Clinical Trials Overview731
    Number of Clinical Trials731
    Patient Recruitment Status741
    Prevalence of Disease in India, China and Brazil (2010-2017)741
    Coverage741
    Secondary Research741
    Primary Research751
    Expert Panel Validation751
  Contact Us751
  Disclaimer751
  Sources761

Table Of Contents

GBI Research Reports—GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.

About the Author


Cite this Report

  
MLA:
GBI Research Reports. "Clinical Trial Recruitment in Respiratory Diseases - Most Clinical Trial Activity Focused on Asthma and COPD" Nov 22, 2011. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Clinical-Trial-Recruitment-in-Respiratory-Diseases-Most-Clinical-Trial-Activity-Focused-on-Asthma-and-COPD-2115-307>
  
APA:
GBI Research Reports. (2011). Clinical Trial Recruitment in Respiratory Diseases - Most Clinical Trial Activity Focused on Asthma and COPD Nov 22, 2011. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Clinical-Trial-Recruitment-in-Respiratory-Diseases-Most-Clinical-Trial-Activity-Focused-on-Asthma-and-COPD-2115-307>
  
US$ 3,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.